A Single Centre, Randomised, Double-blind, Three-period Cross-over Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
Phase of Trial: Phase I
Latest Information Update: 10 Jan 2018
At a glance
- Drugs Insulin degludec/liraglutide (Primary) ; Insulin degludec; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 05 Jan 2018 Status changed from active, no longer recruiting to completed.
- 02 Jan 2018 Planned End Date changed from 9 Feb 2018 to 3 Jan 2018.
- 02 Jan 2018 Planned primary completion date changed from 9 Feb 2018 to 3 Jan 2018.